AYTU BIOPHARMA, INC. (AYTU) Net margin 2017–2026
AYTU BIOPHARMA, INC. (AYTU) net profit margin by fiscal year — reported net income divided by reported revenue.
-24.8%FY2026 · since FY2017: -698.7% → -24.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -24.8% | -4.3 pp |
| FY2025 | -20.4% | +3.9 pp |
| FY2024 | -24.3% | -8.4 pp |
| FY2023 | -15.9% | +96.7 pp |
| FY2022 | -112.5% | -23.7 pp |
| FY2021 | -88.8% | -39.5 pp |
| FY2020 | -49.3% | +321.3 pp |
| FY2019 | -370.6% | -92.3 pp |
| FY2018 | -278.3% | +420.3 pp |
| FY2017 | -698.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AYTU financial trends
AYTU RevenueAYTU Net incomeAYTU Gross profitAYTU Gross marginAYTU Operating incomeAYTU Operating marginAYTU Operating cash flowAYTU Free cash flowAYTU Capital expendituresAYTU Return on equityAYTU Stock buybacksAYTU Dividends paidAYTU Total assetsAYTU Total liabilitiesAYTU Shareholders’ equityAYTU overview →